Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs)
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 10, Pages 1059
Publisher
MDPI AG
Online
2021-10-20
DOI
10.3390/ph14101059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
- (2021) Hui Xian Jaime Lin et al. INFECTION
- Novel Polymorph of Favipiravir—An Antiviral Medication
- (2021) Alexander S. Goloveshkin et al. Pharmaceutics
- The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
- (2021) Zain Chagla ANNALS OF INTERNAL MEDICINE
- Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro
- (2021) Richa Vartak et al. Nanomedicine
- A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2
- (2021) Burcu Ucar et al. NANOTECHNOLOGY
- Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection
- (2021) Basanth Babu Eedara et al. Pharmaceutics
- In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
- (2021) Sawittree Sahakijpijarn et al. International Journal of Pharmaceutics: X
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
- (2020) Fang Jiang et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD)
- (2020) Monika Yadav et al. Drug Delivery and Translational Research
- Nanotechnology for COVID-19: Therapeutics and Vaccine Research
- (2020) Gaurav Chauhan et al. ACS Nano
- Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group
- (2020) Jolyon P. Mitchell et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Pathological changes in the lungs and lymphatic organs of twelve COVID-19 autopsy cases
- (2020) Qian Liu et al. National Science Review
- Role of favipiravir in the treatment of COVID-19
- (2020) Shashank Joshi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
- (2020) Ahmed Mostafa et al. Pharmaceuticals
- Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
- (2019) Egor Tchesnokov et al. Viruses-Basel
- Simvastatin Nanoparticles Reduce Inflammation in LPS-Stimulated Alveolar Macrophages
- (2019) Alaa S. Tulbah et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhaled rapamycin solid lipid nano particles for the treatment of Lymphangioleiomyomatosis
- (2019) Emelie Landh et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficient antiviral co-delivery using polymersomes by controlling the surface density of cell-targeting groups for influenza A virus treatment
- (2018) Haejin Chun et al. Polymer Chemistry
- Lyophilized Hybrid Nanostructured Lipid Carriers to Enhance the Cellular Uptake of Verapamil: Statistical Optimization and In Vitro Evaluation
- (2018) Arshad Ali Khan et al. Nanoscale Research Letters
- Inhaled simvastatin nanoparticles for inflammatory lung disease
- (2017) Alaa S Tulbah et al. Nanomedicine
- Synthesis and Characterization of Inhalable Flavonoid Nanoparticle for Lung Cancer Cell Targeting
- (2016) Wing-Hin Lee et al. Journal of Biomedical Nanotechnology
- Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity
- (2015) Wing-Hin Lee et al. Journal of Biomedical Nanotechnology
- Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
- (2015) Wing-Hin Lee et al. Asian Journal of Pharmaceutical Sciences
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals
- (2014) Mona H Aburahma et al. Expert Opinion on Drug Delivery
- Respirable nanocarriers as a promising strategy for antitubercular drug delivery
- (2014) Mohammed M. Mehanna et al. JOURNAL OF CONTROLLED RELEASE
- Preparation of Tween 80-Zn/Al-Levodopa-Layered Double Hydroxides Nanocomposite for Drug Delivery System
- (2014) Aminu Umar Kura et al. TheScientificWorldJOURNAL
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Triggered nanoparticles as therapeutics
- (2013) Chang Soo Kim et al. Nano Today
- The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
- (2013) Zhinan Jin et al. PLoS One
- Efficacy of a combination of simvastatin and poly(DL-lactic-co-glycolic acid) in stimulating the regeneration of Bone Defects
- (2012) Kyl Assaf et al. Materials Research-Ibero-american Journal of Materials
- Characterization of biomolecular nanoconjugates by high-throughput delivery and spectroscopic difference
- (2012) Robert K DeLong et al. Nanomedicine
- Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia
- (2012) Hui Xin Ong et al. PHARMACEUTICAL RESEARCH
- TWEEN coated NaYF4:Yb,Er/NaYF4 core/shell upconversion nanoparticles for bioimaging and drug delivery
- (2012) Wenlu Ren et al. RSC Advances
- Formulation strategy and use of excipients in pulmonary drug delivery
- (2010) Gabrielle Pilcer et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor
- (2010) Mohamed E. Abdelrahim PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Simvastatin Release from Poly(lactide-co-glycolide) Membrane Scaffolds
- (2010) Hassan Rashidi et al. Polymers
- RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo
- (2009) Preetha Anand et al. BIOCHEMICAL PHARMACOLOGY
- Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion
- (2008) Zih-rou HUANG et al. ACTA PHARMACOLOGICA SINICA
- Targeted delivery of nanoparticles for the treatment of lung diseases
- (2008) Shirzad Azarmi et al. ADVANCED DRUG DELIVERY REVIEWS
- Loading of curcumin into macrophages using lipid-based nanoparticles
- (2007) Keitaro Sou et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search